VERU Financial Statements From 2010 to 2024
| FMW Stock | EUR 0.68 0.01 1.45% |
Check VERU INC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VERU INC's main balance sheet or income statement drivers, such as , as well as many indicators such as . VERU financial statements analysis is a perfect complement when working with VERU INC Valuation or Volatility modules.
VERU |
VERU INC DL 01 Company Profit Margin Analysis
VERU INC's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current VERU INC Profit Margin | (2.13) % |
Most of VERU INC's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VERU INC DL 01 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, VERU INC DL 01 has a Profit Margin of -2.1288%. This is 81.01% lower than that of the Healthcare sector and 90.76% lower than that of the Biotechnology industry. The profit margin for all Germany stocks is 67.62% higher than that of the company.
VERU INC DL Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining VERU INC's current stock value. Our valuation model uses many indicators to compare VERU INC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VERU INC competition to find correlations between indicators driving VERU INC's intrinsic value. More Info.VERU INC DL 01 is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VERU INC's earnings, one of the primary drivers of an investment's value.About VERU INC Financial Statements
VERU INC stakeholders use historical fundamental indicators, such as VERU INC's revenue or net income, to determine how well the company is positioned to perform in the future. Although VERU INC investors may analyze each financial statement separately, they are all interrelated. For example, changes in VERU INC's assets and liabilities are reflected in the revenues and expenses on VERU INC's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in VERU INC DL 01. Please read more on our technical analysis and fundamental analysis pages.
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. VERU INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3 people.
Currently Active Assets on Macroaxis
Other Information on Investing in VERU Stock
VERU INC financial ratios help investors to determine whether VERU Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in VERU with respect to the benefits of owning VERU INC security.